Get the Stockscreener App
5.46
2.06%
0.11
After Hours:
5.46
Endra Life Sciences Inc stock is traded at $5.46, with a volume of 8,038.
It is up +2.06% in the last 24 hours and up +1.11% over the past month.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
See More
Previous Close:
$5.35
Open:
$5.4
24h Volume:
8,038
Relative Volume:
0.08
Market Cap:
$6.93M
Revenue:
-
Net Income/Loss:
$-7.03M
P/E Ratio:
-0.6126
EPS:
-8.9134
Net Cash Flow:
$-8.20M
1W Performance:
+8.12%
1M Performance:
+1.11%
6M Performance:
+26.98%
1Y Performance:
+74.44%
1-Day Range:
$5.40
$5.55
1-Week Range:
$4.97
$5.97
52-Week Range:
$2.915
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
5.46 | 6.79M | 0 | -7.03M | -8.20M | -8.9134 |
TMO
Thermo Fisher Scientific Inc
|
448.28 | 167.00B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.00 | 122.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
559.37 | 43.63B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
342.37 | 33.48B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.96 | 32.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
Endra Life Sciences Inc Stock (NDRA) Latest News
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - The Chronicle-Journal
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
NDRA News | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
Endra Life Sciences reports Q1 EPS ($1.09) vs. ($1.86) last year - TipRanks
NDRA Strengthens Clinical Foundation for TAEUS Liver Technology - GuruFocus
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) faces Nasdaq equity notice after Q1 loss - Stock Titan
ENDRA Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ENDRA Life (NDRA) Q4 2025 Results Miss Estimates — EPS $-3.26 vs $-1.25Expert Stock Picks - Newser
NDRA Q1'26 Earnings: EPS estimate is (1.23) USD - TradingView
Endra Life Sciences (NDRA) Achieves Promising Results with TAEUS Liver - GuruFocus
Endra Life Sciences reports multi-site validation of TAEUS Liver device - TipRanks
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accu - PharmiWeb.com
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility - BioSpace
ENDRA reports multi-site validation results for liver imaging device - Investing.com UK
ENDRA reports multi-site validation results for liver imaging device By Investing.com - Investing.com Australia
Liver Device Demonstrating MRI-like Accuracy and Reproducibility - Business Wire
TradingKey - tradingkey.com
ENDRA Life Sciences (NASDAQ: NDRA) Heats Up as Diagnostic Play - openPR.com
Is ENDRA Life (NDRA) stock suitable for your portfolio? (Nudges Down) 2026-04-27Senior Analyst Forecasts - Newser
ENDRA Life Sciences (NDRA) price target decreased by 10.00% to 27.54 - MSN
ENDRA Life (NDRA) Stock Chart | Q4 2025: Earnings Fall ShortFree Cash Margin - Xã Châu Thành
ENDRA Life Sciences Faces Renewed Nasdaq Listing Compliance Risk - The Globe and Mail
ENDRA Life Sciences Inc. Files Form 8-K with SEC – Company Details, Address, and Compliance Information (April 2026) 23 - Minichart
Endra Life Sciences receives Nasdaq delisting notice over equity requirement - Investing.com
ENDRA Life Sciences Received Notice of Delisting - TradingView
Equity shortfall puts ENDRA Life Sciences (NASDAQ: NDRA) at renewed Nasdaq delisting risk - Stock Titan
ENDRA Life (NDRA) Stock: Price Action (Declines) 2026-04-20Trend Analysis - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS Registered Liver Imaging Technology - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology - Barchart.com
Aug Fed Impact: What is the PEG ratio of ENDRA Life Sciences IncMarket Movers & Fast Momentum Entry Tips - baoquankhu1.vn
Is ENDRA Life (NDRA) Stock Good for Portfolio | Price at $4.95, Down 6.78%Volatility Skew - Newser
Aug Fed Impact: Whats the MACD signal for ENDRA Life Sciences IncGDP Growth & Long-Term Safe Investment Ideas - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Is ENDRA Life (NDRA) Stock Near Resistance | Price at $5.10, Down 4.49%Smart Money Flow - Newser
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside - Barchart
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 - openPR.com
Retail Surge: Is ENDRA Life Sciences Inc exposed to currency risks2026 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn
ENDRA Life Sciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView — Track All Markets
ENDRA (NDRA) Optimistic About TAEUS Technology's Potential - GuruFocus
ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) flags going-concern risk and pivots to digital asset treasury - Stock Titan
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):